Abdominal sacrocolpopexy with Pelvicol xenograft and concomitant Burch colposuspension

Figures & data

Figure 1 Abdominal sacrocolpopexy.

Notes: (A) Three single suture (Etibond; Ethicon, Somerville, NJ, USA) submitted in Lig. longitudinal ligament. (B and C) Pelvicol implant fixed between promontorium and vaginal stump. (D) Peritoneal closure above the Pelvicol through continuous suture (Vicryl; Ethicon).

Table 1 Preoperative characteristics of patients

	Study group (n=27)
Age (year, mean ± SD)	69±10
Body mass index (kg/m^2, mean ± SD)	25.6±3.2
Parity (n ± SD)	3±2
ASA (n [%])
ASA I	13 (48.2)
ASA II	8 (29.6)
ASA III	5 (18.5)
ASA IV	1 (3.7)
Prolapse stage (n [%])
POP-Q I	3 (11.1)
POP-Q II	7 (25.9)
POP-Q III	13 (48.2)
POP-Q IV	4 (14.8)
Additional descensus (n [%])
Anterior compartment	7 (27.9)
Posterior compartment	4 (14.8)
Symptoms (n [%])
Stress incontinence	14 (51.9)
Urge incontinence	3 (11.1)
Mixed incontinence	4 (14.8)
Voiding dysfunction/residual urinary	6 (22.2)
Dyspareunia	8 (29.6)
Vaginal pain	12 (44.4)
History of urogynecological operations (n [%])
Hysterectomy	11 (40.7)
TVT (tension free tape)	3 (11.4)
Burch	2 (7.4)

Abbreviations: ASA, american society of anaesthesiologists; POP-Q, pelvic organ prolapse quantification; SD, standard deviation.

Table 2 Urinary symptoms preoperative and at follow-up

	Preoperative (n [%])	Follow-up (n [%])	P-value
Pads (mean ± SD, range)	4.8±2.6 (3–10)	1±1.9 (0–5)	0.001
Voiding frequency (mean ± SD, range)	8±2.8 (4–13)	4±1 (3–6)	0.0001
Residual urinary (mean, mL)	165	35	0.0001
Dysuria	14	5	0.002
Nocturia (mean ± SD, range)	4±2 (3–9)	2±1 (1–5)	0.001

Table 3 Additional procedure and perioperative complications and anatomical failure

	n (%)
Additional procedure
Hysterectomy	3 (11)
Uterus myomas excision	1 (3.7)
Adhesiolyse	7 (26)
Insertion of suprapubic catheter	15 (56)
Ovarian cyst extirpation	1 (3.7)
Adenectomy	1 (3.7)
Perioperative complications
Urinary tract infection	2 (7.4)
Wound healing deficit	1 (3.7)
Incisional hernia	1 (3.7)
Anatomical failure	2 (7.4)